Showing results (31-40 of 440) with videos related to
Sort By:
Pageof 44
Thrombosis and Haemostasis|October 16, 2015
Incorporating edoxaban into the choice of anticoagulants for atrial fibrillationJeffrey I Weitz, John EikelboomCanadian Journal of Surgery. Journal Canadien De Chirurgie|April 15, 2003
Thromboprophylaxis in surgical patientsMartin O'Donnell, Jeffrey I WeitzThrombosis and Haemostasis|June 9, 2017
New developments in anticoagulants: Past, present and futureJeffrey I Weitz, Job HarenbergThe American Journal of Managed Care|May 22, 2004
Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillationMartin O'Donnell, Jeffrey I WeitzClinics in Laboratory Medicine|May 15, 2026
Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to KnowJeffrey I Weitz, David GailaniAnnals of Internal Medicine|April 6, 2026
In the ED, the Wells score plus age-adjusted D-dimer score ruled out DVT with a failure rate ≤0.8% at 3 moConor Bell, Jeffrey I Weitz, Thrombosis and Haemostasis|March 23, 2018
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban StudiesAlok A Khorana, Jeffrey I WeitzAnnals of Internal Medicine|November 1, 2021
In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 moNoel C Chan, Jeffrey I WeitzCurrent Drug Targets. Cardiovascular & Haematological Disorders|December 20, 2003
An update on new anticoagulantsLori-Ann Linkins, Jeffrey I WeitzPageof 44